Literature DB >> 29515411

Rosai-Dorfman Disease Complicated by Autoimmune Hemolytic Anemia in a Child: A Case Report and Review of the Literature.

Amer A Lardhi1, Abdullah K Al-Mutairi1, Mohammed H Al-Qahtani1, Atheer K Al-Mutairi1.   

Abstract

Rosai-Dorfman disease is a rare histiocytic proliferative disorder that commonly presents with a massive lymphadenopathy and a variety of constitutional symptoms. Severe hemolytic anemia is an infrequent complication of this disease. Although the etiology of the condition is unknown, infectious agents including viruses have been implicated. We describe a 2-year-old female child who presented with fever, pallor, and generalized lymphadenopathy complicated by the development of autoimmune hemolytic anemia. A review of the literature of this condition is also provided.

Entities:  

Keywords:  Autoimmune hemolytic anemia; Herpes simplex virus; Massive lymphadenopathy; Rosai-Dorfman disease; Sinus histiocytosis

Year:  2018        PMID: 29515411      PMCID: PMC5836236          DOI: 10.1159/000485968

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Case Report

A previously healthy 2-year-old female toddler from Sudan was admitted to the pediatric ward with the chief complaints of fever, weight loss, fatigability, pallor, and generalized lymphadenopathy. The symptoms started 2 months before presentation. Upon admission, the patient looked unwell, irritable, pyretic, pale, and had tachycardia. Anthropometric measurements were within normal values for age and sex. Widespread lymph node enlargement was observed in the head and neck region, as well as the presence of bilateral axillary nodes, and inguinal nodes (Fig. 1). The liver was felt 4 cm and the spleen 9 cm below the costal margins. Laboratory tests revealed anemia with a hemoglobin of 4.7 g/dL, high reticulocyte count 19.3%, red blood cells (RBC) 0.81 × 106/µL, mean cell volume 130.8 fL, leukocyte count of 16.5 × 103/µL with 78% neutrophils, 8% lymphocytes, 7% eosinophils, and 7% basophils. The platelets were normal: 244 × 103/µL. The peripheral blood smear showed marked red blood cell agglutination along with polychromatic and spherocytic cells and nucleated RBC, consistent with acute hemolysis. The direct antiglobulin test (Coombs) was strongly positive a finding suggestive of autoimmune hemolytic anemia. The blood chemistry revealed increased levels of lactate dehydrogenase 426 U/L, low albumin levels 1.4 g/dL with normal serum bilirubin and liver enzymes. The erythrocyte sedimentation rate was elevated to 50 mm by the end of first hour and the C-reactive protein was 10.6 mg/dL. The microbiology screen was negative when the body fluids were tested. The serology test was unremarkable for Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus, Brucella, and toxoplasma. Herpes simplex virus IgG and IgM tests were positive. The tuberculin skin test was negative. The chest and abdominal CT scan revealed perihilar lymphadenopathy, para-aortic lymphadenopathy, and hepatosplenomegaly. The bone marrow aspirate revealed reactive hypercellular bone marrow with Mott cells (active plasma cells) and abnormal histiocytes with a high hemophagocytic activity (Fig. 2). A lymph node biopsy from the anterior cervical group (Fig. 3) showed that the sinusoids were extended and filled with S100 and CD68-positive but CD1a-negative histiocytes with abundant cytoplasmic fat globules and exhibited emperipolesis (viable lymphocytes inside the cytoplasm of histiocytes). The histiocytes were surrounded predominantly by a lymphocytic and plasmocytic infiltrate with formation of Russell bodies (plasma cells with large inclusions containing immunoglobulins).
Fig. 1.

Lymph node enlargement. a Postauricular. b Left inguinal.

Fig. 2.

Bone marrow aspirate showing plasma cells actively producing immunoglobulins “Mott cells” (a) and hemophagocytosis of RBC and neutrophils (b).

Fig. 3.

Lymph node biopsy showing: large histiocytes with emperipolesis (black arrows) and plasma cells with large inclusions containing immunoglobulins “Russel body” (yellow arrow) (a); immunohistochemical staining of lymph node biopsy, positive for S100 (b); immunohistochemical staining of lymph node biopsy, positive for CD68 (c); immunohistochemical staining of lymph node biopsy, negative for CD1a (d); and immunohistochemical staining of lymph node biopsy, negative for CD21 (e).

The patient received one unit of packed RBC which temporarily raised her hemoglobin level to 6.1 g/dL; however, with the ongoing hemolysis, the hemoglobin dropped to 3.8 g/dL. Treatment was then started with 2 mg/kg/day of prednisolone. The patient showed a rapid clinical and laboratory improvement. The fever subsided by the third day of steroid therapy, and the lymph nodes became softer to palpation toward the end of the first week of the treatment. The hemoglobin increased to 8.7 g/dL and the level reached 11.3 g/dL upon discharge. The steroid treatment was tapered, and it was discontinued 4 months after presentation. The patient achieved clinical and laboratory remission with no evidence of hemolysis and had a negative direct Combs test.

Discussion

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymph adenopathy, is a rare, mostly benign histiocytic disorder [1, 2]. It is characterized by the proliferation and accumulation of histiocytes in the lymph nodes, but can also involve extranodal sites [3, 4]. Although this disorder was described, initially by Rosai and Dorfman in young Africans, the disease is reported worldwide, and no racial group is spared. The etiology of the disease remains uncertain. The presence of autoimmune antibodies during the disease activity along with the several reports confirming serological evidence of recent bacterial or viral infection mainly herpes viruses suggests a possible link with an immune deregulatory activity secondary to infection [5, 6, 7]. The serological evidence of recent herpes simplex infection, may suggest a possible correlation with the RDD in our patient. Acute life-threatening autoimmune hemolytic anemia has been described in several reports [8, 9, 10]. However, only 4 pediatric patients [11, 12, 13], including our case, with significant acute autoimmune hemolytic anemia, have been identified (Table 1). All patients had lymphadenopathy and symptoms of anemia upon presentation, along with low hemoglobin, high reticulocytes, and a strong positive direct antiglobulin test. In addition to blood transfusion, management of RDD has ranged from only steroid treatment, as in our patient, to the use of chemotherapeutic agents in resistant cases. The disease outcome among patients appears to be similar. However, a 7-year-old boy from Nigeria had a disease course complicated by sickle-cell anemia, infections, and cardiac failure secondary to dilated cardiomyopathy (Table 1).
Table 1

Summary of clinical and laboratory findings in children with Rosai-Dorfman disease and anemia

Patient [Ref.]Age/genderRaceClinical presentationHgb level, g/dLTreatmentOutcome
1 [7]10 years/MBlack/IndianLNP, HSM, pallor6.4Vincristine, cyclophosphamide, prednisoloneDCT negative, Hgb 10, HSM regressed, responded partially to chemotherapy

2 [8]7 years/MBlack/NigerianSCD, intermittent LNP, pallor2.6Chronic blood transfusion, frequent admission and antibioticsDCT remained positive, infectious complications, dilated cardiomyopathy

3 [9]18 months/MBlack/SudaneseFever, LNP, HSM, pallor4.3PrednisoloneDCT n.a., HSM regressed responded partially, steroid for 1 year

4 [this report]2 years/FBlack/SudaneseFever, LNP, HSM, pallor4.7Prednisolone for 4 monthsDCT negative, Hgb 11.3, HSM regressed, responded well

Hgb, hemoglobin; SCD, sickle cell disease, LNP, lymphadenopathy; HSM, hepatosplenomegaly; DCT, direct Coombs test; n.a., not applied.

The value of this report lies in the association of autoimmune hemolytic anemia with RDD in the presence of serological evidence of a recent herpes simplex virus, which further supports the hypothesis of an altered immunological process triggered by a viral illness.

Statement of Ethics

The authors have no ethical conflicts to declare.

Disclosure Statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.
  12 in total

1.  The digestive system manifestations of Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy): review of 11 cases.

Authors:  G Y Lauwers; A Perez-Atayde; R F Dorfman; J Rosai
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

Review 2.  Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates.

Authors:  S A Grabczynska; C T Toh; N Francis; C Costello; C B Bunker
Journal:  Br J Dermatol       Date:  2001-08       Impact factor: 9.302

3.  Sinus histiocytosis with massive lymphadenopathy: complicated by autoimmune hemolytic anemia.

Authors:  Penukonda Sasi Kiran; Vasantha Prema Sowdi; Sumanth B Shetty; U Venugopal; S Parameshwariah; Edwin Dias; C S Kamala
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

4.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

5.  Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations.

Authors:  Y Mehraein; M Wagner; K Remberger; L Füzesi; P Middel; S Kaptur; K Schmitt; E Meese
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

6.  The Rosai-Dorfman disease histiocytes are not infected by Epstein-Barr virus.

Authors:  W Y Tsang; T T Yip; J K Chan
Journal:  Histopathology       Date:  1994-07       Impact factor: 5.087

7.  Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  P H Levine; N Jahan; P Murari; M Manak; E S Jaffe
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

8.  Sinus histiocytosis with massive lymphadenopathy.

Authors:  E Foucar; J Rosai; R F Dorfman
Journal:  Arch Otolaryngol       Date:  1978-12

9.  Rosai-Dorfman disease: a previously unreported association with sickle cell disease.

Authors:  Claire Stebbing; Jon van der Walt; Ghada Ramadan; Baba Inusa
Journal:  BMC Clin Pathol       Date:  2007-04-02

10.  A rare case of rosai-dorfman disease in an adult male associated with auto-immune hemolytic anemia.

Authors:  Mickey Sachdeva; Haifaa Abdulhaq
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-10       Impact factor: 2.576

View more
  2 in total

Review 1.  Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.

Authors:  Hind Abdin Salama; Abdul Rahman Jazieh; Ayman Yahya Alhejazi; Ahmed Absi; Saeed Alshieban; Mohsen Alzahrani; Ahmed Alaskar; Giamal Gmati; Moussab Damlaj; Khadega A Abuelgasim; Abdulrahman Alghamdi; Bader Alahmari; Areej Almugairi; Hazza Alzahrani; Ali Bazarbachi; M O H Musa; Gaurav Goyal
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-08-18

2.  Rosai-Dorfman disease with renal involvement and associated autoimmune haemolytic anaemia in a 12-year-old girl: A case report.

Authors:  Tharmini Danisious; Mathula Hettiarachchi; Chanuka Dharmadasa; Heshan Jayaweera
Journal:  BMC Pediatr       Date:  2020-10-08       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.